Novel treatment of locally advanced cutaneous squamous cell carcinoma with cemiplimab: a case report

Int J Dermatol. 2021 Feb;60(2):233-235. doi: 10.1111/ijd.15176. Epub 2020 Sep 21.

Authors

Rachel Nelson¹, Ly Luu², Peter Silberstein³, Manasa Velagapudi⁴, Christopher Huerter¹

Affiliations

¹ Division of Dermatology, Creighton University School of Medicine, Omaha, NE, USA.
² Department of Pathology, Creighton University School of Medicine, Omaha, NE, USA.
³ Division of Hematology and Oncology, Creighton University School of Medicine, Omaha, NE, USA.
⁴ Division of Infectious Disease, Creighton University School of Medicine, Omaha, NE, USA.

PMID: 32955136
DOI: 10.1111/ijd.15176

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Antineoplastic Agents, Immunological* / therapeutic use
Carcinoma, Squamous Cell* / drug therapy
Humans
Skin Neoplasms* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
cemiplimab